Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind active-controlled study of topiroxostat tablets in gout with hyperuricemia
CTR20242688Phase 2Completed
- Sponsor
- Hebei Kaiwei Hengcheng Pharmaceutical
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topiroxostat in gout, hyperuricemia, sponsored by Hebei Kaiwei Hengcheng Pharmaceutical. Started Sep 2024; status: completed.
02
Drugs
topiroxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on CTR20242688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242688.